Monday, April 20, 2026
wellness India Expo
Home Tags Biotech

Tag: Biotech

4baseCare partners with France-based Owkin to advance inclusive cancer research

Through this collaboration, the two companies will work together to convert fragmented cancer care data into AI-ready intelligence

Zydus launches biosimilar Aflibercept 2 mg ANYRA™ for advancing ophthalmic care

ANYRA™ is India’s first indigenously developed Aflibercept 2 mg biosimilar 

BioAsia 2026 positions Telangana as a global TechBio powerhouse

The mega life-sciences event is preparing to launch its 23rd edition on February 17–18. 2026

Rx Propellant appoints Ashish Singh as its CEO & MD

With over three decades of experience across real estate, investment management and business consulting, Ashish has successfully built and scaled institutional platforms across emerging asset classes

BioAsia 2026 to convene world’s leading science, AI & industry pioneers...

Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health

Budget 2026: OPPI calls ‘Biopharma Shakti’ India’s leap toward global leadership

The Budget’s focused push on biologics and biosimilars, backed by a dedicated biopharma innovation network, was described by Matai as positioning India strongly for the next wave of complex, high-value therapies

Analyst values Vyome’s VT-1953 at USD 1 Billion upon successful completion...

Third-party analysis estimates the total addressable U.S. market to be approximately USD 2.2 billion

Merck Healthcare R&D India unveils next-gen office in Bangalore to power...

Championing collaboration, India’s technological advances, and scientific excellence for future-ready R&D in Merck Healthcare

S&P Global upgrades Biocon Biologics credit rating to BB+

The upgrade follows Biocon’s recent equity issuance undertaken to settle the compulsorily convertible preference shares (CCPS) issued to Viatris Inc.

Beyond Trade: How the EU–India FTA reshapes life-sciences industry

The deal represents nearly 25% of global GDP and one-third of global trade, making it one of the most consequential trade agreements of this era